DEA confirms it is reviewing marijuana rescheduling recommendation
The U.S. Drug Enforcement Administration is currently "conducting its review" of an earlier recommendation that the agency reschedule…
News January 4
Latest In: Drug Enforcement Administration
DEA warns Georgia pharmacies to halt low-THC medical marijuana oil sales
The U.S. Drug Enforcement Administration is warning traditional Georgia pharmacies that marijuana possession and sales are federally prohibited.
News December 8
Canadian producer MediPharm exports cannabis oil to US for clinical trial
Canadian marijuana producer MediPharm Labs said it completed a shipment of cannabis oil containing both CBD and THC…
News August 1
No timeline on Biden administration marijuana rescheduling, DEA chief says
The Biden administration has yet to provide the U.S. Drug Enforcement Administration a “specific timeline” to complete its…
News July 28
Marijuana cultivator Bright Green secures $3.5 million private placement
An institutional investor has agreed to buy more than 3 million shares in Florida-based marijuana cultivation company Bright…
News May 23
How Biden’s rescheduling of marijuana could affect the US industry
After a half-century in which marijuana endured the strictest prohibition allowed under the law, President Joe Biden has…
News October 14
DEA awards seventh cannabis cultivation license for research
Maridose has been licensed by the U.S Drug Enforcement Administration and Department of Justice for the bulk manufacture…
News August 19
Marijuana grower Bright Green tumbles to Earth after initial Nasdaq stock surge
Bright Green Corp. made history last month as the first plant-touching marijuana business to trade on a major…
News June 15
DEA prevails in hemp extract fight that one judge calls ‘ridiculous’
Low-THC hemp extracts become illegal marijuana the moment they exceed o.3% THC, a federal appeals court ruled, dismissing a…
News June 13Featured
1
Latest Sponsored
